SAMR Bans 30 Common Wellness Marketing Phrases: Key Takeaways for Foreign Brands
On January 15, 2024, China’s State Administration for Market Regulation (SAMR, 国家市场监督管理总局, guójiā shìchǎng jiāndū guǎnlǐ zǒngjú) published an updated list of 30 prohibited marketing phrases for health supplements, functional foods, and wellness products. The ban applies to all advertising, packaging, and social media promotions, directly impacting over 3,200 foreign-invested enterprises (外商独资企业, WFOE, wàishāng dúzī qǐyè) active in China’s health sector. This marks the third such crackdown since 2020, but the current list is the most specific yet — replacing the previous 17-phrase ban of 2022.
Why SAMR Acted Now: Three Triggers Behind the Ban
China’s health supplement market reached RMB 362 billion in 2023, up 14.7% year-over-year. However, SAMR found that 73% of online wellness ads examined during Q3 2023 contained at least one prohibited claim. The agency identified three primary drivers for the expanded ban: first, a surge in cross-border e-commerce sales where foreign brands used unverified “miracle cure” language; second, rising consumer complaints filed via the 12315 platform — up 41% in 2023 compared to 2022 — specifically targeting anti-aging and immunity-boosting claims; and third, pressure from provincial food and drug administrations to harmonize enforcement after 17 provinces issued conflicting local guidelines.
The 30 Banned Phrases: What Changed
SAMR’s new list replaces the previous 17-phrase ban and adds 13 entirely new prohibitions. For the first time, the list targets comparative claims (e.g., “stronger than traditional medicine”), time-specific guarantees (e.g., “results in 7 days”), and disease-treatment implications (e.g., “lowers blood sugar naturally”). The table below shows 10 representative phrases from the banned list, with direct English translations and enforcement examples.
| # | Banned Phrase (中文) | English Translation | Category | Typical Violation Context |
|---|---|---|---|---|
| 1 | 根治 | genzhi (completely cure) | Disease treatment | Weight-loss teas |
| 2 | 七天见效 | qī tiān jiàn xiào (results in 7 days) | Time guarantee | Hair growth tonics |
| 3 | 比传统药物更安全 | bǐ chuántǒng yàowù gèng ānquán (safer than traditional medicine) | Comparative claim | Joint health supplements |
| 4 | 抗衰老 | kàng shuāilǎo (anti-aging) | Unsubstantiated effect | Collagen drinks |
| 5 | 降血糖 | jiàng xuètáng (lowers blood sugar) | Disease treatment | Herbal powders |
| 6 | 抑制癌细胞 | yìzhì ái xìbāo (inhibits cancer cells) | Disease treatment | Mushroom extracts |
| 7 | 无副作用 | wú fùzuòyòng (no side effects) | Absolute claim | Sleep aids |
| 8 | 全球认证 | quánqiú rènzhèng (globally certified) | False authority | Probiotic supplements |
| 9 | 一天见效 | yī tiān jiàn xiào (works in one day) | Time guarantee | Digestive enzymes |
| 10 | 替代药品 | tìdài yàopǐn (replace medication) | Disease treatment | Vitamin D preparations |
The full list of 30 phrases is available on SAMR’s official gazette. Notably, 12 of the 17 phrases from the 2022 ban were retained, while 5 were dropped due to low enforcement relevance. The new additions all relate to claims that SAMR found most prevalent in cross-border e-commerce listings during 2023.
Enforcement and Penalties: What Foreign Brands Face
SAMR has signaled stricter enforcement through three mechanisms: random online market sweeps conducted quarterly, mandatory ad pre-vetting for health supplements sold via Tmall Global and JD Worldwide, and a new whistleblower reward system offering up to RMB 200,000 for verified reports. Penalties range from a minimum fine of RMB 100,000 per infraction up to 5% of annual revenue for repeat offenders. In the first month alone (January 15 to February 15, 2024), SAMR issued administrative fines totaling RMB 4.7 million against 23 companies — 11 of which were foreign brands or their Chinese distributors.
Impact on Foreign Health Brands in China
Foreign wellness brands face three immediate operational challenges under the new ban: first, packaging redesign costs — brands with existing inventory bearing banned phrases must recall or relabel, with estimated costs of RMB 50,000 to RMB 300,000 per SKU depending on volume; second, social media retraction — posts on WeChat, Xiaohongshu, and Douyin containing banned phrases must be deleted within 30 days of notice; and third, platform delisting risk — repeat violations can result in 14-day store suspensions on major e-commerce platforms. Australian supplement brand Swisse and US-based GNC have already announced voluntary compliance programs, while smaller foreign entrants without dedicated China legal teams face higher exposure.
SAMR has also mandated that all functional claim substantiation must be filed with the China Food and Drug Administration (CFDA, 国家食品药品监督管理局, guójiā shípǐn yàopǐn jiāndū guǎnlǐ jú) within 90 days of product launch. This requirement, previously only enforced for drugs, now applies to any health supplement making structure-function claims. Brands that fail to file face immediate removal from market platforms and cumulative fines up to RMB 500,000 per unverified claim.
Adapting Your Marketing Strategy: Four Actionable Steps
Foreign brands should take four immediate steps to ensure compliance without losing marketing effectiveness. Step 1: Audit all current product labels, packaging, and digital content — including influencer collaborations — against the full 30-phrase list. Step 2: Replace banned phrases with SAMR-permitted alternatives, such as “supports normal immune function” instead of “boosts immunity.” Step 3: File CFDA substantiation for all existing and planned functional claims — this process takes 45–60 days on average and costs RMB 15,000–RMB 50,000 per claim depending on the evidence required. Step 4: Train local marketing and legal teams on the new guidelines, and include compliance checkpoints in all campaign approval workflows.
What This Means for Market Entry Decisions
For foreign executives evaluating China market entry in the health and wellness space, the ban introduces a new compliance layer that directly affects speed-to-market and cost structure. Companies marketing products with strong disease-treatment angles or time-specific promises face the highest adjustment burden. Conversely, brands that focus on general wellness positioning — using phrases like “dietary supplement” or “part of a healthy lifestyle” — and invest in CFDA claim substantiation from the outset will face minimal disruption. The key shift is from aggressive marketing language to evidence-based communication — a change that aligns with China’s broader regulatory push toward consumer protection and product transparency.
NEXT STEPS
Based on this regulatory update, foreign executives should take the following three actions:
- Complete a compliance audit immediately. Use our China Health Claims Audit Checklist to review your current marketing materials against the full banned list and file CFDA substantiation for all functional claims within 30 days.
- Redesign your China go-to-market strategy. If your product relies on anti-aging or disease-treatment language, consult our guide on Wellness Brand Market Entry for Foreign Companies to reposition your brand using permitted claims without losing consumer trust.
- Monitor cross-border e-commerce compliance. Platforms like Tmall Global are now actively scanning for banned phrases. Read our analysis on 2024 Cross-Border E-Commerce Advertising Rules to understand how this affects your China sales channel.
— China Gateway 360 —
Remote China market entry support, built around execution.
